This binding triggers the tumor cells to release brain-derived neurotrophic factor (BDNF), which enhances cancer innervation via activation of host neurotrophic receptor tyrosine kinase B receptors (NTRK2), thereby establishing a feed-forward loop of sustained signaling. This evidence concerns the gene BDNF and cancer.